Review
Aug 2026
In vivo CAR-T therapy: The shift from ex vivo culturing to direct in situ immune reprogramming.
This review highlights key engineering strategies enabling in vivo CAR T-cell generation, summarizes emerging clinical research and development, and discusses future opportunities for expanding in vivo CAR T-cell therapies as scalable immunotherapy platforms.
Janani Gopalakrishnan, B. Rathod, Sachin Puri
· International Immunopharmaco... · 0 citations